GenomeWeb is hosting a virtual expert panel to discuss challenges, opportunities, and controversies related to informing clinicians, cancer patients, and their families of potential germline insights after receiving somatic testing.
This case-based discussion will provide an overview of best practices and lost opportunities, along with examples of the impact of current reporting practices on clinicians, patients, and their families.
Our panelists will bring their expert perspectives to this issue, representing stakeholders in oncology, molecular pathology, and genetic counseling.
They will discuss the pros and cons of reporting potential germline insights as part of the standard of care, and will address questions related to best practices, cost considerations, informed consent, liability, confirmatory testing, and the impact on patient care.
Offered Free by: LGC SeraCare Life Sciences
See All Resources from: LGC SeraCare Life Sciences